People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina has appointed Elizabeth Brady to be VP of global supply chain and Emily Winn-Deen to be VP of diagnostics development.

Brady, who formerly was a VP at Boston Scientific, will run global sourcing, planning, logistics, and distribution operations. Winn-Deen previously was VP of Genetics and Oncology R&D at Cepheid, and she was involved in diagnostics at Roche Molecular Systems, Applera, Oncor, and Bayer Diagnostics.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.